Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

hMedicine Archive

Showing 341 to 360 of 362      First | Prev | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 | Next | Last
Artist who Severed His Hand Has Ability to Paint Again Thanks to Hadassah University Medical Center
Although he severely severed the palm of his hand, Sa'ad El-Kikh, an artist from the village of Tsurif near Hebron, is able to draw and paint once again thanks to a special tool affixed to his hand by Hadassah University Medical Center physical therapists. Date: 10/24/2011


Clinical Trial at Hadassah Hospital Yields Positive Results With Noninvasive Test for Liver Cancer
A clinical trial conducted at the Hadassah University Medical Center has revealed that BreathID, a new noninvasive device for the detection of hepato-cellular carcinoma, a type of liver cancer, achieved diagnostic results similar to CT Scans and MRIs. BreathID was developed by Exalenz Bioscience Ltd., whose Medical Director is Prof. Yaron Ilan, Director of Hadassah's Department of Internal Medicine. Date: 10/24/2011


Clinical Trial Begins at Hadassah University Medical Center with New Drug to Treat Stroke
A Phase IIa clinical trial with a medicine to treat ischemic stroke has begun at Hadassah, based on the research of Prof. Abd Al-Roof Higazi, head of the Department of Clinical Biochemistry at Ein-Kerem. Date: 10/24/2011


Diabetes Cure Moves a Step Closer with new Hadassah/Hebrew University Research
Hope for a future cure of insulin-dependent (type 1) diabetes received a boost from the research findings of a multi-year project. Read about it Date: 10/24/2011


Hadassah Medical Center Professor Elected "Director at Large" for Prestigious Radiopharmaceutical Society
Prof. Eyal Mishani, who established Hadassah's Cyclotron Radiochemistry Unit, was elected to serve as "Director at Large" on the five-member Executive of the Society of Radiopharmaceutical Sciences (SRS). Date: 10/24/2011


Hadassah Medical School Graduate Named Chief Executive Officer of Harvard’s Teaching Hospital--Beth Israel Deaconess Medical Center
Dr. Kevin Tabb, a graduate of the Hadassah-Hebrew University School of Medicine, is the new President and CEO of Beth Israel Deaconess Medical Center, the teaching hospital of Harvard University. Date: 10/24/2011


Hadassah Physician Predicts Use of Medical Marijuana Will Grow
The number of authorizations for medical marijuana could reach as high as 40,000 in the next five years, predicts Dr. Elyad Davidson of the Hadassah University Medical Center's Pain Management Clinic. Date: 10/24/2011


Hadassah’s Physicians Council Sponsors Program in Jerusalem in Coordination with Centennial Celebration
Hadassah's Physicians Council Sponsors Program in Jerusalem in Coordination with Centennial Celebration Hadassah's National Physicians Council will be hosting a pre-Centennial Convention Continuing Education Program in Jerusalem, Oct. 14-15, 2012. Date: 10/24/2011


Liver Disease Early Diagnosis Device Developed at Hadassah Medical Center Receives Exemption from FDA, Providing Fast Track for Approval
BreathID, a noninvasive early diagnosis device for acute liver failure developed at the Hadassah University Medical Center, has been fast-tracked by the FDA toward approval. Date: 10/24/2011


Placental Cells Found to Have Potential to Mitigate Acute Radiation Syndrome
"In pre-clinical studies," notes Prof. Raphael Gorodetsky, head of the Biotechnology and Radiobiology Laboratory at the Sharrett Institute of Oncology at Hadassah University Medical Center, "we found that placental-derived cells potentially have the ability to increase the survival rate of animals following exposure to lethal doses of total body irradiation." Date: 10/24/2011


Reunion at Hadassah Commemorates Saving of Life by Organ Recipient Families who Later Became Organ Donors
Three families whose lives were intertwined by organ transplantation reunited recently at Hadassah University Medical Center to commemorate the saving of life following the tragic death of loved ones. Date: 10/24/2011


Saving a Toddler with a Huge Liver Tumor: a Hadassah Patient Success Story
Diagnosed with an extremely large liver tumor, two-year-old Ilana was treated by the Hadassah University Medical Center’s multidisciplinary team with an individualized course of chemotherapy directly into the arteries of her liver. Despite the difficulty of such a procedure in a small child weighing less than 22 pounds, Ilana is now a happy, healthy baby. Date: 10/24/2011


Virtual Reality to the Rescue at Hadassah University Medical Center for Victims of Post-Traumatic Stress
With an expertise in diagnosing and treating Post-Traumatic Stress Disorder (PTSD), the Hadassah University Medical Center is now combining the results of its research with the latest cyberspace technology to help victims of bus bombings who are suffering from PTSD. Date: 9/13/2011


Hadasit Launches New Jewish-Arab Biomedical Community Initiative
Hadasit, the Hadassah University Medical Center’s technology transfer company, has launched an incubator for joint Jewish-Arab biomedical ventures in northern Israel. Date: 9/12/2011


Hadassah and Leading Israeli Supermarket Chain Join Forces To Promote Healthy Eating
Joining forces with one of Israel's leading supermarket chains--Rami Levy Shivuk Hashikma--The Hadassah University Medical Center recently launched an innovative project to increase the sales of healthy food products by offering them at discounted prices. Date: 9/12/2011


Hadassah Medical Center and Israel Defense Forces Team Up to Give Palestinian and Israeli Children a Trip to the Zoo
The Israel Defense Forces' Civil Administration and the Hadassah University Medical Center teamed up this summer to organize a trip to Jerusalem's Biblical zoo for Palestinian children and their families from the West Bank. Date: 9/12/2011


Hadassah University Medical Center Clinical Trial Reveals Success of New Treatment Combination for Post-Traumatic Stress Disorder
Results of a clinical trial at the Hadassah University Medical Center indicate that Deep Transcranial Magnetic Stimulation (TMS) can be an effective treatment for Post-Traumatic Stress Disorder (PTSD) when combined with exposure to trauma memory cues. Date: 9/12/2011


Hundreds of Physicians and Researchers Attend International Conference on Hair Chaired By Hadassah Dermatologist
Hundreds of heath professionals and scientists from over 30 countries participated in the European Hair Research Society's conference in Jerusalem in July, exploring innovative treatments for chronic diseases and sharing the latest developments in tackling various hair disorders. Prof. Abraham Zlotogorsky, Director of Hadassah's Hair Clinic and Laboratory of Genetic Diseases of the Hair and Skin, chaired the Conference. Date: 9/12/2011


Pediatric Intensive Care at Hadassah Hospital-Ein Kerem: Doubling the Capacity
The Hadassah University Medical Center is expanding its Pediatric Intensive Care Unit to ensure that more children are treated with the highest quality acute care in a setting that matches the excellence of the treatment Read the stories of two critically ill young children who were nurtured back to health in Hadassah’s PICU and learn more about Hadassah’s vision for the new unit. Date: 9/12/2011


Saudi Arabian Media Puts Positive Spotlight on Hadassah Medical Center’s Bone Marrow Registry Outreach to Arabs
The Saudi Arabian newspaper, Al-Watan (The Homeland) recently published an article by one of its columnists about Israel's superiority in science and technology and showcased the Hadassah University Medical Center’s Bone Marrow Registry outreach to Arabs. Date: 9/12/2011


Showing 341 to 360 of 362      First | Prev | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 | Next | Last


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

    |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America